It is also available in Mexico. Historically, oxandrolone has been marketed in Argentina, Australia, Brazil, France, Italy, Japan, and Spain, but it appears to no longer be available in these countries. Legal status
In the United States, oxandrolone is categorized as a Schedule III controlled substance under the Controlled Substances Act along with many other AASs. It is a Schedule IV controlled substance in Canada, and a Schedule 4 controlled drug in the United Kingdom. Doping in sports
Oxandrolone is sometimes used as a doping agent in sports. Cases of doping with oxandrolone by professional athletes have been reported. References
External links
Oxandrin Homepage, savientpharma.com (via archive.org)
Oxandrin Label, fda.gov (retrieved 23 October 2009)
"Oxandrolone Side Effects, Interactions and Information". drugs.com.
Clinical trial number NCT03338816 for "ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)" at ClinicalTrials.gov